Grown Rogue International (GRUSF) Net Margin Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Net Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -1,235.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -404.00 |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -1,076.00 |
| Jul 31, 2023 | 8,997.00 |
| Apr 30, 2023 | 11,683.00 |
| Jan 31, 2023 | 16,600.00 |
| Jan 31, 2022 | 56,383.00 |
| Jul 31, 2021 | 21,299.00 |
| Apr 30, 2021 | 12,724.00 |
| Jan 31, 2021 | 27,952.00 |
| Aug 31, 2014 | -157,057.00 |
| Aug 31, 2013 | 10,684.00 |
| May 31, 2013 | 1,795.00 |
| Feb 28, 2013 | -19,782.00 |
| Aug 31, 2012 | 44,981.00 |
| May 31, 2012 | -63,311.00 |
| Feb 29, 2012 | -399,310.00 |